Published in Lancet Respir Med on September 09, 2014
Small airway dysfunction and flow and volume bronchodilator responsiveness in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis (2015) 0.90
Paradoxical response to bronchodilators in COPD: curious enigma or clinically important phenotype? Lancet Respir Med (2014) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med (1999) 29.97
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med (2004) 18.60
A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis (1992) 15.92
Susceptibility to exacerbation in chronic obstructive pulmonary disease. N Engl J Med (2010) 15.07
Genetic epidemiology of COPD (COPDGene) study design. COPD (2010) 7.67
Outcomes for COPD pharmacological trials: from lung function to biomarkers. Eur Respir J (2008) 5.38
Evaluation of clinical methods for rating dyspnea. Chest (1988) 4.12
Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2008) 3.70
Bronchodilator responsiveness in patients with COPD. Eur Respir J (2008) 3.13
Bronchodilator subsensitivity to salbutamol after twice daily salmeterol in asthmatic patients. Lancet (1995) 2.79
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
Paradoxical deterioration in lung function after nebulised salbutamol in wheezy infants. Lancet (1987) 2.09
Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76
Ethnic-specific differences in bronchodilator responsiveness among African Americans, Puerto Ricans, and Mexicans with asthma. J Asthma (2007) 1.57
Paradoxical bronchospasm associated with the use of inhaled beta agonists. J Allergy Clin Immunol (1990) 1.55
Racial and gender differences in susceptibility to tobacco smoke among patients with chronic obstructive pulmonary disease. Respir Med (2005) 1.55
COPD: racial disparities in susceptibility, treatment, and outcomes. Clin Chest Med (2006) 1.54
Pattern of emphysema distribution in alpha1-antitrypsin deficiency influences lung function impairment. Am J Respir Crit Care Med (2004) 1.43
Beta2-adrenergic receptor polymorphisms in African American children with status asthmaticus. Pediatr Crit Care Med (2006) 1.42
Airway dimensions in COPD: relationships with clinical variables. Respir Med (2010) 1.30
Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. Lancet Respir Med (2013) 1.25
Inhaled corticosteroids and augmented bronchodilator responsiveness in Latino and African American asthmatic patients. Ann Allergy Asthma Immunol (2008) 1.23
Automated telecommunication to obtain longitudinal follow-up in a multicenter cross-sectional COPD study. COPD (2012) 1.15
Burden of COPD, asthma, and concomitant COPD and asthma among adults: racial disparities in a medicaid population. Chest (2009) 1.03
Paradoxical bronchospasm after use of inhalation aerosols: a review of the literature. J Asthma (1991) 0.96
FEV(1)/FEV(6) to diagnose airflow obstruction. Comparisons with computed tomography and morbidity indices. Ann Am Thorac Soc (2014) 0.93
Criteria for the assessment of reversibility in airways obstruction. Report of the Committee on Emphysema American College of Chest Physicians. Chest (1974) 0.88
Lack of paradoxical bronchoconstriction after administration of tiotropium via Respimat® Soft Mist™ Inhaler in COPD. Int J Chron Obstruct Pulmon Dis (2011) 0.81
Paradoxical bronchospasm: a potentially life threatening adverse effect of albuterol. South Med J (2006) 0.81
Paradoxical response to levalbuterol. J Am Osteopath Assoc (2008) 0.81
Paradoxical bronchoconstriction with albuterol administered by metered-dose inhaler and nebulizer solution. Ann Pharmacother (2005) 0.81
Paradoxical bronchospasm and cutaneous rash after metered-dose inhaled bronchodilators. Monaldi Arch Chest Dis (1996) 0.79
Paradoxical bronchoconstriction with nebulized albuterol but not with terbutaline. Am Rev Respir Dis (1993) 0.78
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Lung volumes and emphysema in smokers with interstitial lung abnormalities. N Engl J Med (2011) 4.75
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Comparison of spirometric thresholds in diagnosing smoking-related airflow obstruction. Thorax (2013) 2.88
The clinical features of the overlap between COPD and asthma. Respir Res (2011) 2.29
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
The chronic bronchitic phenotype of COPD: an analysis of the COPDGene Study. Chest (2011) 2.14
Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPDGene Study. Am J Respir Crit Care Med (2011) 2.06
A genome-wide association study of COPD identifies a susceptibility locus on chromosome 19q13. Hum Mol Genet (2011) 1.98
Interstitial lung abnormalities and reduced exercise capacity. Am J Respir Crit Care Med (2012) 1.80
Clinical and radiographic predictors of GOLD-unclassified smokers in the COPDGene study. Am J Respir Crit Care Med (2011) 1.76
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
Association Between Interstitial Lung Abnormalities and All-Cause Mortality. JAMA (2016) 1.61
Genome-wide association identifies regulatory Loci associated with distinct local histogram emphysema patterns. Am J Respir Crit Care Med (2014) 1.57
Reduced Bone Density and Vertebral Fractures in Smokers. Men and COPD Patients at Increased Risk. Ann Am Thorac Soc (2015) 1.54
β-Blockers are associated with a reduction in COPD exacerbations. Thorax (2015) 1.48
Quantitative computed tomography of the lungs and airways in healthy nonsmoking adults. Invest Radiol (2012) 1.41
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med (2012) 1.27
The clinical impact of non-obstructive chronic bronchitis in current and former smokers. Respir Med (2013) 1.23
Genome-wide association study of smoking behaviours in patients with COPD. Thorax (2011) 1.18
Association between Functional Small Airway Disease and FEV1 Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 1.07
Epidemiology, genetics, and subtyping of preserved ratio impaired spirometry (PRISm) in COPDGene. Respir Res (2014) 1.06
Six-minute walk distance predictors, including CT scan measures, in the COPDGene cohort. Chest (2011) 1.03
Association between airway caliber changes with lung inflation and emphysema assessed by volumetric CT scan in subjects with COPD. Chest (2011) 1.03
Paired inspiratory-expiratory chest CT scans to assess for small airways disease in COPD. Respir Res (2013) 1.00
Family history is a risk factor for COPD. Chest (2011) 0.96
Racial differences in CT phenotypes in COPD. COPD (2013) 0.95
Exome Sequencing Analysis in Severe, Early-Onset Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.92
Pulmonary function reduction in diabetes with and without chronic obstructive pulmonary disease. Diabetes Care (2013) 0.89
Association between occupational exposure and lung function, respiratory symptoms, and high-resolution computed tomography imaging in COPDGene. Am J Respir Crit Care Med (2014) 0.89
Clinical, physiologic, and radiographic factors contributing to development of hypoxemia in moderate to severe COPD: a cohort study. BMC Pulm Med (2016) 0.87
Analysis of Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Defined on the Basis of Bronchodilator Response and Degree of Emphysema. Ann Am Thorac Soc (2016) 0.87
Characterizing functional lung heterogeneity in COPD using reference equations for CT scan-measured lobar volumes. Chest (2013) 0.86
Risk factors for COPD exacerbations in inhaled medication users: the COPDGene study biannual longitudinal follow-up prospective cohort. BMC Pulm Med (2016) 0.86
Comparison between an alternative and the classic definition of chronic bronchitis in COPDGene. Ann Am Thorac Soc (2015) 0.85
Impact of self-reported gastroesophageal reflux disease in subjects from COPDGene cohort. Respir Res (2014) 0.84
Childhood pneumonia increases risk for chronic obstructive pulmonary disease: the COPDGene study. Respir Res (2015) 0.84
Admixture mapping identifies a quantitative trait locus associated with FEV1/FVC in the COPDGene Study. Genet Epidemiol (2014) 0.82
Exome Array Analysis Identifies a Common Variant in IL27 Associated with Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2016) 0.81
Cardiovascular disease is associated with COPD severity and reduced functional status and quality of life. COPD (2014) 0.81
Persistent and Newly Developed Chronic Bronchitis Are Associated with Worse Outcomes in Chronic Obstructive Pulmonary Disease. Ann Am Thorac Soc (2016) 0.80
Obesity is Associated with Increased Morbidity in Moderate to Severe COPD. Chest (2016) 0.79
Effect of Emphysema Severity on the Apnea-Hypopnea Index in Smokers with Obstructive Sleep Apnea. Ann Am Thorac Soc (2016) 0.79
Phenotypic and genetic heterogeneity among subjects with mild airflow obstruction in COPDGene. Respir Med (2014) 0.78
CT-derived Biomechanical Metrics Improve Agreement Between Spirometry and Emphysema. Acad Radiol (2016) 0.78
Airway wall thickness is increased in COPD patients with bronchodilator responsiveness. Respir Res (2014) 0.78
Lung Mass in Smokers. Acad Radiol (2016) 0.77
A genome-wide association study identifies risk loci for spirometric measures among smokers of European and African ancestry. BMC Genet (2015) 0.77
Current Smoking Status Is Associated With Lower Quantitative CT Measures of Emphysema and Gas Trapping. J Thorac Imaging (2016) 0.77
Pneumothorax risk factors in smokers with and without chronic obstructive pulmonary disease. Ann Am Thorac Soc (2014) 0.77
Common Genetic Polymorphisms Influence Blood Biomarker Measurements in COPD. PLoS Genet (2016) 0.77
Roflumilast and dyspnea in patients with moderate to very severe chronic obstructive pulmonary disease: a pooled analysis of four clinical trials. Int J Chron Obstruct Pulmon Dis (2014) 0.77
Childhood-onset asthma in smokers. association between CT measures of airway size, lung function, and chronic airflow obstruction. Ann Am Thorac Soc (2014) 0.77
Biomechanical CT metrics are associated with patient outcomes in COPD. Thorax (2017) 0.77
Sex-specific features of emphysema among current and former smokers with COPD. Eur Respir J (2015) 0.76
Genetic loci associated with chronic obstructive pulmonary disease overlap with loci for lung function and pulmonary fibrosis. Nat Genet (2017) 0.76
Multiplanar MDCT measurement of esophageal hiatus surface area: association with hiatal hernia and GERD. Surg Endosc (2015) 0.76
Acute Exacerbations and Lung Function Loss in Smokers With and Without COPD. Am J Respir Crit Care Med (2016) 0.75
GDF-15 plasma levels in chronic obstructive pulmonary disease are associated with subclinical coronary artery disease. Respir Res (2017) 0.75
Ventricular Geometry From Non-contrast Non-ECG-gated CT Scans: An Imaging Marker of Cardiopulmonary Disease in Smokers. Acad Radiol (2017) 0.75
Genetic Association and Risk Scores in a COPD Meta-Analysis of 16,707 Subjects. Am J Respir Cell Mol Biol (2017) 0.75
Handgrip Strength in Chronic Obstructive Pulmonary Disease. Associations with Acute Exacerbations and Body Composition. Ann Am Thorac Soc (2017) 0.75
Efficacy of an inhaled corticosteroid/long-acting β2-agonist combination in symptomatic COPD patients in GOLD groups B and D. Eur Respir J (2015) 0.75
Clinical and Genetic Associations of Objectively Identified Interstitial Changes in Smokers. Chest (2017) 0.75
Signs of Gas Trapping in Normal Lung Density Regions in Smokers. Am J Respir Crit Care Med (2017) 0.75
Post-imaging pulmonary nodule mathematical prediction models: are they clinically relevant? Eur Radiol (2019) 0.75
CT Measure of Lung At-risk and Lung Function Decline in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med (2017) 0.75
Lobar Emphysema Distribution Is Associated With 5-Year Radiological Disease Progression. Chest (2017) 0.75